The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...

Sleep apnea “occurs when a person’s upper ... The approval of Zepbound follows a series of other weight loss drugs approved to treat medical conditions other than obesity and diabetes.

tells PEOPLE that some conditions improved by anti-obesity drugs are related to weight loss, not the drugs themselves.

Obesity is more than a cosmetic concern. It’s a chronic disease that can be treated with drugs like semaglutide (Wegovy) and ...

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The ...

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea ... which doesn't cover drugs solely for weight loss.Without insurance coverage ...